Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Management of COVID-19

Food and Drug Administration
Health / Medical / National

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

November 25, 2020November 24, 2020 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate …

Read More

Coronavirus COVID-19
Infectious Diseases / National

FDA Authorizes Drug Combination for Treatment of COVID-19

November 22, 2020November 21, 2020 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or …

Read More
COVID-19
Health / Medical / National

FDA Approves First Treatment for COVID-19

October 25, 2020October 24, 2020 - by MyChesCo

The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least …

Read More

Food and Drug Administration
Government / Health / Medical / National

FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19

August 31, 2020August 31, 2020 - by MyChesCo

As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to …

Read More
VA Announces New Clinical Trial for Veterans with COVID-19
Government / Infectious Diseases / National

VA Announces New Clinical Trial for Veterans with COVID-19

August 31, 2020August 31, 2020 - by MyChesCo

WASHINGTON, D.C.  — The Department of Veterans Affairs (VA) recently announced a new clinical trial to study convalescent plasma for treating seriously ill COVID-19 patients as part of a larger effort …

Read More

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment
Government / Health / Medical / National

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment

August 26, 2020August 26, 2020 - by MyChesCo

The U.S. Food and Drug Administration this week issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the …

Read More

Most Read

  • Bill Gates-Funded Solar Dimming Project Risks the Lives of Millions and Must be Stopped
  • Pennsylvanians Overwhelmingly Support Joining RGGI: PennEnvironment
  • Last-Minute Changes To Tax Laws Included in IRS Forms and Instructions
  • Pennsylvania Experiences Record Firearm Background Checks in Fourth Quarter 2020
  • Do You Know This Alleged Tattooed Shoplifter?
  • Coatesville Manager Discusses Importance of Diversity, Inclusion and Transparency

Subscribe for Updates

Chester County Events

  • National Irish Coffee Day at The Watermark at Bellingham Drive-By
    • 01/21/2021
  • A Real-Life Scavenger Hunt for Grown-Ups On King Street,Malvern!
    • 01/21/2021
      Malvern
  • Intro to Practical Defensive Pistol (Indoor)
    • 01/27/2021
      Elverson
  • Pistol Level 1
    • 01/31/2021
      Malvern
  • Women Willpower Topic: High Value Projects | Host: Lisa Morris
    • 02/09/2021
      West Chester
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • Department of Health Highlights December 2020 Nursing Home Inspection, Sanction Information Amidst COVID-19 Pandemic
  • Secretary of Health Announces Week-Seven of Regional Testing Extension Across the Commonwealth
  • Investcorp Invests in Unilog to Accelerate Growth
  • Nationwide Study Shows Continued Rise in Opioid Affected Births
Copyright © 2021 MyChesCo.